Drawing for LIDIA-SEQ

USPTO serial 79448554

LIDIA-SEQ

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
LARKEY, MICHAEL M
Law office
TMO LAW OFFICE 116

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with LIDIA-SEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments; scientific research and laboratory apparatus; apparatus for conducting PCR analysis; apparatus for DNA and RNA amplification and sequencing for research purposes; apparatus for semiconductor sequencing; apparatus for on-chip DNA and RNA amplification sequencing and measurement; silicon transistors; microchips; data processing equipment; computer software; bioinformatics software; software for microbial pathogen detection and identification; computer software for the diagnosis of sepsis, infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; semiconductors and microchips for sequencing and measurement of DNA and RNA for scientific medical research and veterinary purposes; all for scientific research purposes.ACTIVE—
010Medical and veterinary apparatus and instruments; apparatus for providing diagnostic sequencing of blood samples, DNA and RNA; apparatus for microbial pathogen detection and identification; apparatus for the diagnosis and monitoring of sepsis and infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; apparatus for DNA and RNA testing for medical purposes; apparatus for the diagnosis and monitoring of cancer; apparatus for testing blood samples, cancer cells, DNA, RNA and protein; apparatus for PCR analysis and DNA and RNA sequencing for medical and veterinary purposes; medical diagnostic apparatus for taking and storing blood samples; vials and other containers in the nature of tubes for blood and other medical sample collection; single use cartridges for use in medical apparatus for analysing biological samples; medical diagnostic test kits for the detecting, analysis and monitoring of medical conditions; medical diagnostic apparatus for testing patient biological samples and monitoring of patients; semiconductors and microchips for sequencing and measurement of DNA and RNA for medical and veterinary purposes.ACTIVE—
042Scientific and technological services; laboratory services in the testing, sequencing and measurement of DNA and RNA; medical laboratory services; laboratory analysis; data storage services; software as a service (SaaS) services featuring software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; consultancy and advisory services relating to the aforesaid services.ACTIVE—
044Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services; medical laboratory services for the analysis of samples taken from patients; provision of information relating to the analysis of DNA and RNA; genetic testing for medical purposes; genome sequencing and analysis services for medical and veterinary diagnostic and treatment purposes; medical diagnostic testing, monitoring and reporting services; consultancy and advisory services relating to the aforesaid services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026CRSNCORRECTION SENT TO IB—
Oct 1, 2026CRCRCORRECTION CREATED FOR IB—
Sep 12, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 11, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2026DOCKASSIGNED TO EXAMINER—
Apr 23, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance